Form 4: Outset Medical Executive Sells Shares to Cover Tax Obligations
SEC Form 4
John L. Brottem, General Counsel of Outset Medical, sold 3,011 shares of common stock to cover tax withholding obligations related to vesting RSUs.
Summary
- On August 15, 2024, John L. Brottem, the General Counsel of Outset Medical, Inc., sold 3,011 shares of the company's common stock.
- The sale was executed at a price of $0.84 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of 5,887 shares of common stock underlying Restricted Stock Units (RSUs).
- The RSUs were granted to Mr. Brottem on March 15, 2021, January 26, 2022, and January 6, 2023.
- Following the transaction, Mr. Brottem still beneficially owns 230,295 shares of Outset Medical, Inc.
- The sale was a 'sell to cover' transaction to satisfy tax obligations and not a discretionary trade.
Sentiment
Score: 6
Explanation: Neutral sentiment. The transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's outlook on the company.
Positives
- The transaction was explicitly stated as a 'sell to cover' to meet tax obligations, indicating it wasn't a discretionary sale based on the executive's view of the company's prospects.
Industry Context
Executive stock sales to cover tax obligations are a common occurrence and generally don't reflect a change in sentiment about the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include RSUs, and 'sell to cover' transactions are a standard method for employees to manage the tax implications of vesting RSUs.
- The size of the sale is relatively small compared to the executive's total holdings, which is typical in these types of transactions.
Stakeholder Impact
- The sale is unlikely to have a significant impact on shareholders, as it is a small percentage of the outstanding shares and is for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 2021/03/15 | Date of RSU grant to the reporting person. |
| 2022/01/26 | Date of RSU grant to the reporting person. |
| 2023/01/06 | Date of RSU grant to the reporting person. |
| 2024/08/15 | Date of stock sale by John L. Brottem. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.